San Diego, CA, United States of America

Mingxian Huang

This inventor holds 13 USPTO granted patents and 4 published patent applications and 2 EPO patents, primarily in Cell Separation Technology. Top assignee: Aviva Biosciences Corporation. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mingxian Huang. Retrieved from https://idiyas.com/inventor/mingxian-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 23.1

 

Average Co-Inventor Count = 8.4

ph-index = 8

Forward Citations = 400(Granted Patents)


Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Cell Detection
Biochips
Ion Transport
Rare Cell Separation
Microdevices
Automated Systems
Fluid Samples
Magnetizable Substances
Electro-Conductive Materials
Compositions
13 patents (USPTO):Explore Patents

Title: Innovator Mingxian Huang: Advancing Cancer Diagnostics

Introduction

Mingxian Huang, based in San Diego, California, is a prominent inventor known for his significant contributions to medical diagnostics. With 13 patents to his name, he has developed groundbreaking methods that enhance the detection and separation of rare cells, particularly in the context of cancer diagnosis. His innovations are paving the way for more effective treatment strategies.

Latest Patents

Huang's latest patents demonstrate his commitment to improving healthcare technology. One such patent focuses on "Methods and compositions for detecting non-hematopoietic cells from a blood sample." This invention addresses the need for enriching rare cells, such as tumor cells, from complex fluid samples like blood. By removing red and white blood cells through non-centrifugation procedures, his method allows for the assessment of non-hematopoietic cells, thereby aiding in diagnosis and prognosis.

Another of his notable patents is titled "Methods and compositions for separating rare cells from fluid samples." This innovation involves methods that enrich rare cells, including cancer cells, from biological samples by performing debulking steps and selectively removing undesirable components. In some embodiments, magnetic beads coupled with specific binding members facilitate the selective removal of these components, creating samples enriched in cells of interest.

Career Highlights

Mingxian Huang has had an impressive career primarily based at Aviva Biosciences Corporation, where he has propelled significant advancements in the domain of cell detection and analysis. His research has not only enhanced the understanding of cancerous cells but also the precision of diagnostic procedures.

Collaborations

Throughout his career, Huang has collaborated with notable colleagues, including Lei Wu and Junquan Xu. Their collective expertise has undoubtedly contributed to the successful development of innovative solutions in the biomedical field.

Conclusion

Mingxian Huang is a trailblazer in the field of cancer diagnostics, with a prolific patent portfolio underscoring his commitment to innovation. His work continues to have a profound impact on medical science, demonstrating the critical role that inventors play in advancing healthcare technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…